Current Report Filing (8-k)
May 15 2019 - 4:29PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 15, 2019
InspireMD,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35731
|
|
26-2123838
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
4
Menorat Hamaor St.
Tel
Aviv, Israel
|
|
6744832
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (888) 776-6804
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.0001
per
share
|
|
NSPR
|
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
On
May 14, 2019, InspireMD, Inc. (the “Company”) announced its Stockholders’ Equity as of March 31, 2019. The
Company is announcing today its
pro forma
Stockholders’ Equity as of March 31, 2019, which incorporates the
closing of the Company’s underwritten public offering of 486,957 shares of its common stock at a price to the public of
$5.00 per share on April 8, 2019, the closing of the exercise of the underwriter’s over-allotment option to purchase an
additional 12,393 shares of its common stock at a price to the public of $5.00 per share (collectively, the “Public
Offering”), and the estimated net loss for the month of April 2019 as of April 30, 2019 (the “Estimated April Net
Loss”). After adjusting for the Public Offering and Estimated April Net Loss, as of April 30, 2019, the Company is
pleased to announce Stockholders’ Equity of approximately $7.0 million on a
pro forma
basis, as of March 31,
2019.
Pro-forma
Stockholders’ Equity
The
following table sets forth the Company’s Stockholders’ Equity position as of March 31, 2019, as adjusted on a
pro
forma
basis to reflect the Public Offering and Estimated April Net Loss as of April 30, 2019:
InspireMD,
INC.
Pro
Forma Stockholder’s Equity
(U.S.
dollars in thousands)
(Unaudited)
Balance at March 31, 2019
|
|
|
5,640
|
|
|
|
|
|
|
Proceeds from the Public
Offering, net
(1)
|
|
|
2,029
|
|
Estimated April
Net Loss
(1) (2)
|
|
|
(671
|
)
|
Pro
forma equity, as of March 31, 2019, as adjusted
(1)
|
|
|
6,998
|
|
(1)
Not reviewed by independent auditors
(2)
Net Loss net of Share Based Compensation as of April 30, 2019
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
InspireMD,
Inc.
|
|
|
|
Date:
May 15, 2019
|
By:
|
/s/
Craig Shore
|
|
Name:
|
Craig
Shore
|
|
Title:
|
Chief
Financial Officer
|
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Aug 2024 to Sep 2024
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Sep 2023 to Sep 2024